[Successful psychopharmacotherapy of anxiety and depressive disorders improve functional limitations in patients with rheumatoid arthritis].
A A AbramkinT A LisitsynaD Yu VeltishchevO F SeravinaO B KovalevskayaSvetlana GlukhovaEvgeniy NasonovPublished in: Terapevticheskii arkhiv (2022)
While ADD do affect functional limitations in patients with RA, PPT tends to attenuate the negative impact of ADD on RA outcomes, and RA patients with functional limitations should therefore be screened for depression and long-term PPT should be recommended.